Expansion of a Sterile Injectable Medication Manufacturing Plant Project

Sandoz Canada is proposing to expand its Boucherville sterile injectable medication manufacturing plant by adding a production unit with an area of about 6,880 square metres southwest of the existing building. The Sandoz plant's production would gradually increase by 2022, from 370 to 700 metric tonnes, following the expansion project. The proposed project would also include the relocation of the access road and drainage ditches as well as the development of traffic and parking areas, sewer manholes and a culvert.

Latest update

May 10, 2013 - The Canadian Environmental Assessment Agency issued its environmental assessment determination and decided that an environmental assessment of the designated project is not required.



Impact Assessment Agency of Canada
160 Elgin Street, 22nd Floor
Ottawa, Ontario K1A 0H3
Telephone: 613-957-0700 or 1-866-582-1884
Fax: 613-957-0862
Email: information@iaac-aeic.gc.ca

  • Location

    • Boucherville (Quebec)
  • Nature of Activity

    • Building and Property Development
  • Assessment Status

  • Proponent

    Sandoz Canada
  • Authorities

    • Canadian Environmental Assessment Agency
  • Assessment Type

    Assessment not applicable
  • Reference Number


This map is for illustrative purposes. The markers represent the approximate locations based on available data. More than one marker may be identified for a given assessment.

Nearby assessments

...within 200 kilometres
Date modified: